BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37521234)

  • 21. Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts.
    Abdel Razik LH; Obaid ZM; Fouda I
    J Cosmet Dermatol; 2021 Oct; 20(10):3341-3346. PubMed ID: 34228877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Study to Evaluate the Role of Intradermal and Intralesional Measles, Mumps, Rubella (MMR) Vaccine in Treatment of Common Warts.
    Gupta P; Tegta GR; Verma GK; Gupta A; Gupta M; Sharma S
    Indian Dermatol Online J; 2020; 11(4):559-565. PubMed ID: 32832442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
    Nofal A; Alakad R; Fouda I; Fawzy MM
    J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of intralesional wart therapy.
    Muse ME; Stiff KM; Glines KR; Cline A; Feldman SR
    Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of Intralesional Vitamin D3 in Cutaneous Warts: An Open Uncontrolled Trial.
    Kavya M; Shashikumar BM; Harish MR; Shweta BP
    J Cutan Aesthet Surg; 2017; 10(2):90-94. PubMed ID: 28852295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
    Rageh RM; Hewedy ES; Hegab DS
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intralesional vitamin D3 versus intralesional purified protein derivative in treatment of multiple warts: A comparative clinical and immunological study.
    Abou-Taleb DAE; Abou-Taleb HA; El-Badawy O; Ahmed AO; Thabiet Hassan AE; Awad SM
    Dermatol Ther; 2019 Sep; 32(5):e13034. PubMed ID: 31355514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
    Nofal A; Nofal E; Yosef A; Nofal H
    Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapeutic modalities for the treatment of recalcitrant plantar warts: a comparative study.
    Nofal A; Albalat W; Ismail A; Khattab FM
    J Dermatolog Treat; 2022 Mar; 33(2):922-927. PubMed ID: 32609022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of intralesional injection of vitamin D
    Elsayed Ghaly N; El-Ashmawy AA; Abou Zeid M; E Shaker ES
    J Cosmet Dermatol; 2021 Apr; 20(4):1231-1240. PubMed ID: 32892493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative clinico-dermoscopic study of intralesional injection of combined digoxin and furosemide, Candida antigen, and vitamin D3 for multiple warts.
    Nasr M; Abdelaty S; Elkholy BM
    J Cosmet Dermatol; 2023 Apr; 22(4):1344-1353. PubMed ID: 36606379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intralesional measles-mumps-rubella is associated with a higher complete response in cutaneous warts: a systematic review and meta-analysis of randomized controlled trial including GRADE qualification.
    Vania R; Pranata R; Tan ST
    J Dermatolog Treat; 2021 Dec; 32(8):1010-1017. PubMed ID: 31985307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
    Nofal A; Adel L; Fawzy M; Elkholy BM
    Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts.
    Tawfik NZ; Eyada MMK; Abdel El Hamid RE; Halim HM
    Dermatol Ther; 2022 Oct; 35(10):e15762. PubMed ID: 36056784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
    Nofal A; Alakad R
    J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.
    Johnson SM; Roberson PK; Horn TD
    Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of autoimplantation therapy and intralesional injection of MMR vaccine in warts treatment.
    ElGhareeb MI
    Dermatol Ther; 2019 Nov; 32(6):e13135. PubMed ID: 31648401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Cryotherapy Combined With Intralesional Purified Protein Derivative (PPD) Versus Intralesional PPD Monotherapy in the Treatment of Multiple Common Warts.
    Awad SM; Gomaa AS; Hassan HA; Tawfik YM
    J Cutan Med Surg; 2023; 27(2):117-125. PubMed ID: 36705474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.
    Awal G; Kaur S
    J Clin Aesthet Dermatol; 2018 May; 11(5):15-20. PubMed ID: 29785233
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative Study of Intralesional Vitamin D3 Injection and Candida Albicans Antigen in Treating Plantar Warts.
    Abdelaal MA; Abdelaziz HM; Ahmed KA; Elsaie ML
    J Drugs Dermatol; 2021 May; 20(5):546-549. PubMed ID: 33938709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.